Functional Screening of FxxLF-Like Peptide Motifs Identifies SMARCD1/BAF60a as an Androgen Receptor Cofactor that Modulates TMPRSS2 Expression

por van de Wijngaart, Dennis J., Dubbink, Hendrikus J., Molier, Michel, de Vos, Carola, Trapman, Jan, Jenster, Guido
Publicado en Mol Endocrinol (2009)

Systematic Structure-Function Analysis of Androgen Receptor Leu(701) Mutants Explains the Properties of the Prostate Cancer Mutant L701H

por van de Wijngaart, Dennis J., Molier, Michel, Lusher, Scott J., Hersmus, Remko, Jenster, Guido, Trapman, Jan, Dubbink, Hendrikus J.
Publicado 2010

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma

por van der Leest, Cor, Wagner, Anja, Pedrosa, Rute M., Aerts, Joachim G., Dinjens, Winand N.M., Dubbink, Hendrikus J.
Publicado en JCO Precis Oncol (2018)

Mitochondrial D310 mutation as clonal marker for solid tumors

por Geurts-Giele, Willemina R. R., Gathier, Gerard H. G. K., Atmodimedjo, Peggy N., Dubbink, Hendrikus J., Dinjens, Winand N. M.
Publicado en Virchows Arch (2015)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

por Groenendijk, Floris H., Taal, Walter, Dubbink, Hendrikus J., Haarloo, Cathleen R., Kouwenhoven, Mathilde C., van den Bent, Martin J., Kros, Johan M., Dinjens, Winand N. M.
Publicado 2010

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples

por Mankor, Joanne M., Paats, Marthe S., Groenendijk, Floris H., Roepman, Paul, Dinjens, Winand N. M., Dubbink, Hendrikus J., Sleijfer, Stefan, Cuppen, Edwin, Lolkema, Martijn P. J. K.
Publicado en Br J Cancer (2020)

Compartmentalization of androgen receptor protein–protein interactions in living cells

por van Royen, Martin E., Cunha, Sónia M., Brink, Maartje C., Mattern, Karin A., Nigg, Alex L., Dubbink, Hendrikus J., Verschure, Pernette J., Trapman, Jan, Houtsmuller, Adriaan B.
Publicado 2007

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

por Synhaeve, Nathalie E., van den Bent, Martin J., French, Pim J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Verdijk, R., Dirven, Clemens M. F., Dubbink, Hendrikus J.
Publicado en Acta Neuropathol Commun (2018)

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers

por Eikenboom, Ellis L., van Doorn, Helena C., Dinjens, Winand N. M., Dubbink, Hendrikus J., Geurts-Giele, Willemina R. R., Spaander, Manon C. W., Tops, Carli M. J., Wagner, Anja, Goverde, Anne
Publicado en Cancers (Basel) (2021)

Next generation diagnostic molecular pathology: Critical appraisal of quality assurance in Europe

por Dubbink, Hendrikus J., Deans, Zandra C., Tops, Bastiaan B.J., van Kemenade, Folkert J., Koljenović, S., van Krieken, Han J.M., Blokx, Willeke A.M., Dinjens, Winand N.M., Groenen, Patricia J.T.A.
Publicado en Mol Oncol (2014)

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

por Broen, Martinus P G, Smits, Marion, Wijnenga, Maarten M J, Dubbink, Hendrikus J, Anten, Monique H M E, Schijns, Olaf E M G, Beckervordersandforth, Jan, Postma, Alida A, van den Bent, Martin J
Publicado en Neuro Oncol (2018)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

por Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Publicado en Front Oncol (2020)

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

por Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Kros, Johan M., French, Pim J., Sanson, Marc, Idbaih, Ahmed, Wesseling, Pieter, Enting, Roelien, Spliet, Wim, Tijssen, Cees, Dinjens, Winand N. M., Gorlia, Thierry, van den Bent, Martin J.
Publicado en Neuro Oncol (2016)

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma

por Wijnenga, Maarten M. J., French, Pim J., Dubbink, Hendrikus J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Fleischeuer, Ruth, Dirven, Clemens M. F., Vincent, Arnaud J. P. E., van den Bent, Martin J.
Publicado en J Neurooncol (2018)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

por van Poppelen, Natasha M., van Ipenburg, Jolique A., van den Bosch, Quincy, Vaarwater, Jolanda, Brands, Tom, Eussen, Bert, Magielsen, Frank, Dubbink, Hendrikus J., Paridaens, Dion, Brosens, Erwin, Naus, Nicole, de Klein, Annelies, Kiliç, Emine, Verdijk, Robert M.
Publicado en Int J Mol Sci (2021)

The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma

por van der Voort, Sebastian R., Incekara, Fatih, Wijnenga, Maarten M.J., Kapsas, Georgios, Gahrmann, Renske, Schouten, Joost W., Dubbink, Hendrikus J., Vincent, Arnaud J.P.E., van den Bent, Martin J., French, Pim J., Klein, Stefan, Smits, Marion
Publicado en Data Brief (2021)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA

por Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., de Jonge, Evert, Dinjens, Winand N. M., van Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.
Publicado en Mol Oncol (2020)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Stu...

por van den Bent, Martin J., Dubbink, Hendrikus J., Sanson, Marc, van der Lee-Haarloo, Cathleen R., Hegi, Monika, Jeuken, Judith W.M., Ibdaih, Ahmed, Brandes, Alba A., Taphoorn, Martin J.B., Frenay, Marc, Lacombe, Denis, Gorlia, Thierry, Dinjens, Winand N.M., Kros, Johan M.
Publicado 2009

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

por Tesileanu, C Mircea S, Dirven, Linda, Wijnenga, Maarten M J, Koekkoek, Johan A F, Vincent, Arnaud J P E, Dubbink, Hendrikus J, Atmodimedjo, Peggy N, Kros, Johan M, van Duinen, Sjoerd G, Smits, Marion, Taphoorn, Martin J B, French, Pim J, van den Bent, Martin J
Publicado en Neuro Oncol (2020)

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

por Wijnenga, Maarten M J, French, Pim J, Dubbink, Hendrikus J, Dinjens, Winand N M, Atmodimedjo, Peggy N, Kros, Johan M, Smits, Marion, Gahrmann, Renske, Rutten, Geert-Jan, Verheul, Jeroen B, Fleischeuer, Ruth, Dirven, Clemens M F, Vincent, Arnaud J P E, van den Bent, Martin J
Publicado en Neuro Oncol (2018)